340 related articles for article (PubMed ID: 19064571)
21. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
22. COX-2 promoter polymorphisms and the association with prostate cancer risk in South African men.
Fernandez P; de Beer PM; van der Merwe L; Heyns CF
Carcinogenesis; 2008 Dec; 29(12):2347-50. PubMed ID: 18974063
[TBL] [Abstract][Full Text] [Related]
23. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
24. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation in the COX-2 gene and the association with prostate cancer risk.
Shahedi K; Lindström S; Zheng SL; Wiklund F; Adolfsson J; Sun J; Augustsson-Bälter K; Chang BL; Adami HO; Liu W; Grönberg H; Xu J
Int J Cancer; 2006 Aug; 119(3):668-72. PubMed ID: 16506214
[TBL] [Abstract][Full Text] [Related]
26. Identification of genetic risk associated with prostate cancer using ancestry informative markers.
Ricks-Santi LJ; Apprey V; Mason T; Wilson B; Abbas M; Hernandez W; Hooker S; Doura M; Bonney G; Dunston G; Kittles R; Ahaghotu C
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):359-64. PubMed ID: 22801071
[TBL] [Abstract][Full Text] [Related]
27. Associations between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 genotypes and haplotypes in the vitamin D receptor gene, ultraviolet radiation and susceptibility to prostate cancer.
Moon S; Holley S; Bodiwala D; Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
Ann Hum Genet; 2006 Mar; 70(Pt 2):226-36. PubMed ID: 16626332
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
29. The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.
Choi SY; Kim HJ; Cheong HS; Myung SC
Korean J Urol; 2015 Jan; 56(1):19-30. PubMed ID: 25598933
[TBL] [Abstract][Full Text] [Related]
30. A novel prostate cancer susceptibility locus at 19q13.
Hsu FC; Sun J; Wiklund F; Isaacs SD; Wiley KE; Purcell LD; Gao Z; Stattin P; Zhu Y; Kim ST; Zhang Z; Liu W; Chang BL; Walsh PC; Duggan D; Carpten JD; Isaacs WB; Grönberg H; Xu J; Zheng SL
Cancer Res; 2009 Apr; 69(7):2720-3. PubMed ID: 19318570
[TBL] [Abstract][Full Text] [Related]
31. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
32. Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo men.
Granados JB; Méndez JP; Feria-Bernal G; García-García E; Tejeda ME; Rojano-Mejía D; Tapia A; Canto P
Urol Oncol; 2017 Mar; 35(3):111.e9-111.e14. PubMed ID: 27843028
[TBL] [Abstract][Full Text] [Related]
33. Methionine Synthase Reductase-A66G and -C524T Single Nucleotide Polymorphisms and Prostate Cancer: A Case-Control Trial.
Basir A
Asian Pac J Cancer Prev; 2019 May; 20(5):1445-1451. PubMed ID: 31127906
[TBL] [Abstract][Full Text] [Related]
34. Localization of cancer susceptibility genes by genome-wide single-nucleotide polymorphism linkage-disequilibrium mapping.
Mitra N; Ye TZ; Smith A; Chuai S; Kirchhoff T; Peterlongo P; Nafa K; Phillips MS; Offit K; Ellis NA
Cancer Res; 2004 Nov; 64(21):8116-25. PubMed ID: 15520224
[TBL] [Abstract][Full Text] [Related]
35. Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer.
Bachmann N; Hoegel J; Haeusler J; Kuefer R; Herkommer K; Paiss T; Vogel W; Maier C
Prostate; 2005 Nov; 65(3):252-9. PubMed ID: 16015586
[TBL] [Abstract][Full Text] [Related]
36. TNF polymorphisms and prostate cancer risk.
Danforth KN; Rodriguez C; Hayes RB; Sakoda LC; Huang WY; Yu K; Calle EE; Jacobs EJ; Chen BE; Andriole GL; Figueroa JD; Yeager M; Platz EA; Michaud DS; Chanock SJ; Thun MJ; Hsing AW
Prostate; 2008 Mar; 68(4):400-7. PubMed ID: 18196539
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder.
Traks T; Koido K; Eller T; Maron E; Kingo K; Vasar V; Vasar E; Kõks S
BMC Med Genet; 2008 Dec; 9():111. PubMed ID: 19087313
[TBL] [Abstract][Full Text] [Related]
38. Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Tang L; Platek ME; Yao S; Till C; Goodman PJ; Tangen CM; Wu Y; Platz EA; Neuhouser ML; Stanczyk FZ; Reichardt JKV; Santella RM; Hsing A; Figg WD; Lippman SM; Thompson IM; Ambrosone CB
Carcinogenesis; 2018 Feb; 39(2):125-133. PubMed ID: 29228205
[TBL] [Abstract][Full Text] [Related]
39. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
[TBL] [Abstract][Full Text] [Related]
40. Specific correlation between the major chromosome 10q26 haplotype conferring risk for age-related macular degeneration and the expression of
Liao SM; Zheng W; Zhu J; Lewis CA; Delgado O; Crowley MA; Buchanan NM; Jaffee BD; Dryja TP
Mol Vis; 2017; 23():318-333. PubMed ID: 28659708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
